FDA Greenlights First Treatment for Deadly Sanfilippo Syndrome
The FDA has approved the first-ever treatment for Sanfilippo syndrome Type A, a rare genetic killer targeting the central nervous system. This gene therapy offers hope for stabilization and prevention, though families are now focused on tackling high costs and access hurdles.
- Original source: wdsu.com.
- The source published it on Nov 16, 2026 at 4:00 PM.
- No second outlet has reported it yet. Treat it as a single-source claim.
>The FDA has officially given the green light for the first-ever treatment for children battling Sanfilippo syndrome Type A. This gene therapy marks a major breakthrough for those fighting this rare and deadly genetic disease.
>The treatment delivers a healthy, functional copy of a gene, allowing the body to produce the enzyme it is genetically deficient in. Cure Sanfilippo Foundation founders noted that the therapy is specifically designed for prevention and stabilization, not reversal.
>Access, however, is complicated. For the treatment to be provided, a child must not have been exposed to the viral vector and must not have antibodies above a certain level. Coverage for the nearly $4 million treatment cost presents another major hurdle for families.
>Glenn and Cara O'Neill, founders of the Cure Sanfilippo Foundation, are pushing for advanced research to develop treatments for other types of Sanfilippo syndrome, including Types B, C, and D.
>Cara Bergeron, mother of Asher Bergeron, shared that the hope is simply to extend his life so his family can enjoy his smile for a little longer.
entities]: [
TopicsFDA · Sanfilippo syndrome · Cure Sanfilippo Foundation · Asher Bergeron · Cara Bergeron · Glenn O'Neill · Cara O'Neill
Source: wdsu.com
Written by AI from verified reporting.
More stories
- Health & science healthandme.com 0 viewsEurope approves Revolution Medicines' RAS-blocking pancreatic cancer pill
- Health & science finance.yahoo.com 0 viewsNovartis' Cosentyx wins FDA nod as first anti-IL-17 biologic for PMR
- Health & science casrai.org 0 viewsFDA greenlights giredestrant-everolimus duo for ESR1-mutated breast cancer
- Health & science nbcnews.com Caught by @nina.anggraini29 0 viewsMeasles Is Endemic Again as the U.S. Loses Its Elimination Status

